Skip to main content
Premium Trial:

Request an Annual Quote

H9, H7 et al. Approved for Federally Funded Research

The Washington Post reports that the National Institutes of Health has approved 13 additional human embryonic stem cell lines as eligible for federal funding this week. On the list is H9 — the most widely used hESC line, developed by researchers at the University of Wisconsin, Madison-affiliated WiCell Research Institute, which had previously been approved under the administration of former President Bush. "Many people who had been working on these lines, and concerned about whether they would be able to continue to work with these lines, will now be reassured that their research can now go forward," NIH Director Francis Collins said Tuesday, according to the Post article.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.